BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7139851)

  • 1. Vindesine: phase II evaluation in colon cancer and description of its platelet stimulating activity.
    Pazdur R; Rossof AH; Chandra G; Bonomi PD; Slayton RE; Wolter J
    Cancer Chemother Pharmacol; 1982; 9(1):41-4. PubMed ID: 7139851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vindesine for metastatic malignant melanoma. A phase II trial.
    Nelimark RA; Peterson BA; Vosika GJ; Conroy JA
    Am J Clin Oncol; 1983 Oct; 6(5):561-4. PubMed ID: 6613921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vindesine in advanced renal cancer. A study of the EORTC Genito-urinary Tract Cancer Cooperative Group.
    Fosså SD; Denis L; van Oosterom AT; de Pauw M; Stoter G
    Eur J Cancer Clin Oncol; 1983 Apr; 19(4):473-5. PubMed ID: 6305668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vindesine in the treatment of metastatic breast cancer.
    Hansen PV; Brincker H
    Eur J Cancer Clin Oncol; 1984 Oct; 20(10):1221-5. PubMed ID: 6541581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II evaluation of vindesine sulfate in patients with advanced sarcomas.
    Sordillo PP; Magill GB; Gralla RJ
    Cancer Treat Rep; 1981; 65(5-6):515-6. PubMed ID: 7237472
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II study of vindesine in patients with metastatic breast cancer.
    Cobleigh MA; Williams SD; Einhorn LH
    Cancer Treat Rep; 1981; 65(7-8):659-63. PubMed ID: 7248983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of vindesine in patients with advanced breast cancer.
    Walker BK; Raich PC; Fontana J; Subramanian VP; Rogers JS; Knost JA; Denning B
    Cancer Treat Rep; 1982 Sep; 66(9):1729-32. PubMed ID: 6288237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vindesine in the treatment of advanced colorectal cancer: a phase II study.
    Diaz-Rubio E; Martin-Jimenez M
    Cancer Treat Rep; 1984 Mar; 68(3):555-6. PubMed ID: 6704985
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessment.
    Kris MG; Gralla RJ; Kalman LA; Kelsen DP; Casper ES; Burke MT; Groshen S; Cibas IR; Bagin R; Heelan RT
    Cancer Treat Rep; 1985 Apr; 69(4):387-95. PubMed ID: 3888388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of esophageal cancer with vindesine: an open trial.
    Bezwoda WR; Derman DP; Weaving A; Nissenbaum M
    Cancer Treat Rep; 1984 May; 68(5):783-5. PubMed ID: 6722833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vindesine in the treatment of small cell anaplastic bronchogenic carcinoma.
    Osterlind K; Dombernowsky P; Sørensen PG; Hansen HH
    Cancer Treat Rep; 1981; 65(3-4):245-8. PubMed ID: 6263469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II evaluation of vindesine in the treatment of colorectal and esophageal tumors.
    Bedikian AY; Valdivieso M; Bodey GP; Freireich EJ
    Cancer Chemother Pharmacol; 1979; 2(4):263-6. PubMed ID: 455586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II trail of vindesine in patients with refractory small-cell carcinoma of the lung.
    Fuks JZ; Aisner J; Carney DN; Van Echo DA; Ostrow SS; Ihde DC; Wiernik PH
    Am J Clin Oncol; 1982 Feb; 5(1):49-52. PubMed ID: 6282108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phase II study of vindesine in patients with primary bronchogenic carcinoma by Cooperative Study Group].
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1838-43. PubMed ID: 6882007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phase II study of vindesine in hematological malignancies].
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2509-15. PubMed ID: 6580841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broad phase II study of vindesine.
    Valdivieso M; Bedikian AY; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1981; 65(9-10):877-9. PubMed ID: 7273021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II evaluation of vindesine for patients with advanced colorectal carcinoma.
    Saiers JH; Slavik M; McKinney DR
    Cancer Treat Rep; 1982 Mar; 66(3):583-4. PubMed ID: 7060047
    [No Abstract]   [Full Text] [Related]  

  • 18. Vindesine in the treatment of squamous cell carcinoma (WHO I), adenocarcinoma (WHO III), and large cell carcinoma (WHO IV) of the lung.
    Ferrazzi E; Zagonel V; Vinante O; Galligioni E; Pappagallo GL; Cartei G; Fiorentino MV
    Tumori; 1982 Dec; 68(6):531-5. PubMed ID: 6301122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I evaluation of vindesine in children: a Southwest Oncology Group pilot study.
    Komp D; Vats T; Shepherd DA; Vietti T; Hoogstraten B; Haas CD
    Med Pediatr Oncol; 1980; 8(3):243-50. PubMed ID: 7193278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapy of carcinoma of the respiratory and digestive tracts with vindesine sulfate. Phase II clinical trial].
    Domenge C; Richard JM
    Ann Otolaryngol Chir Cervicofac; 1984; 101(2):119-21. PubMed ID: 6372615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.